TL
Telix Pharma
TLX.AX·ASXMelbourne AUFounded 2015700 employees
Mid CapbiotechPublicOncology
Platform: Radioligand
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (TLX.AX)
Loading TLX.AX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TLX-9288 | TLX-9288 | Phase 2 | 1 | CD123 | Meso | ||
| TLX-9196 | TLX-9196 | Phase 1/2 | 1 | SHP2 | CSUCeliac | ||
| TLX-9433 | TLX-9433 | Phase 2 | 2 | KRASG12D | NSCLC |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Telix Pharma trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)